Investment
Features
FeesSafety
Academy
More
Pluang+

Compare GE Vernova Inc (GEV) vs Koninklijke Philips NV (PHG) Price & Performance

GE Vernova IncTrade
Koninklijke Philips NVTrade

Price performance (Past 24H)

Key statistics

GE Vernova Inc vs Koninklijke Philips NV — how do they compare? GE Vernova Inc trades at $1,031.62 (market cap $283.57B), while Koninklijke Philips NV trades at $27.22 (market cap $26.29B). The key difference: GE Vernova Inc is far larger — about 10.8× Koninklijke Philips NV's market cap, and Koninklijke Philips NV pays the higher dividend (3.75%). Which is the better fit depends on your goals.

GEVPHG
Market Cap
$283.57B$26.29B
Sector
TechnologyHealth
52-Week High
$1.17K$32.91
52-Week Low
$547.96$24.38
Enterprise Value
$276.21B$32.56B
Dividend Yield
0.19%3.75%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

GE Vernova Inc

No Aura AI signal available yet.

Koninklijke Philips NV

PHG trades at $27.16, up 4.22% today. The stock shows mixed signals with a bearish technical outlook but improving fundamentals, including a return to profitability in 2025 with net income of $895 million. Recent news highlights AI integration in healthcare products and new FDA clearances, supporting growth initiatives. Analyst consensus is divided with 41% buy ratings amid neutral sentiment.

The outlook is cautiously optimistic given earnings recovery and strategic partnerships, but risks include high debt levels and competitive pressures. The stock presents a value opportunity if operational improvements continue, though technical weakness suggests near-term volatility.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About GE Vernova Inc

GE Vernova is a global leader in the electric power industry. It provides sustainable energy solutions across gas, wind, and hydro sectors, focusing on modernizing the world's power grids.

Read more on GEV

About Koninklijke Philips NV

Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. About 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound equipment, image-guided therapy solutions and healthcare informatics. The connected care segment (27% of revenue) encompasses monitoring and analytics systems for hospitals and sleep and respiratory care devices, whereas the personal health business (remainder of revenue) includes electric toothbrushes and men's grooming and personal-care products. In 2021, Philips generated EUR 17.2 billion in sales and had 80,000 employees in over 100 countries.

Read more on PHG